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Thyroid cancer is the most common endocrine cancer, accounting for about 1% of all cancers. 
Sarcomas, lymphomas and metastases to the thyroid gland are rare and only with a handful of 
descriptions in the literature.
Objective: To describe rare histological types of thyroid cancer found in a reference center.
Methods: Medical chart review from admitted patients diagnosed with thyroid cancer in the period 
from 1977 to 2010. Demographic, diagnostic, therapeutic and histopathological information were 
collected.
Results: 3,018 records of patients admitted with thyroid disease were reviewed. Among the cases 
diagnosed with rare tumors there was a predominance of: anaplastic carcinoma: 22 cases (0.7%), 
followed by 11 cases of medullary carcinoma (0.36%); 2 cases of sarcoma (0.07%), 2 cases of lymphoma 
(0.07%) and one case of metastatic carcinoid tumor (0.03%). There were more females diagnosed 
(57%) as well as Caucasians (84%). The most frequent clinical presentation was a palpable thyroid 
nodule. All patients with lymphoma, sarcoma and anaplastic carcinoma died.
Conclusion: Sarcomas, lymphomas and thyroid metastases are uncommon and tend to worse 
outcomes.
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INTRODUCTION
Thyroid cancer is the most common neoplasia of 
the read and neck, representing 1% of all malignant tu-
mors in the age range between 30 and 74 years, with a 
three fold higher prevalence in women, when compared 
to men, although such difference drops after 48 years 
of age1. In a North-American statistics, it corresponds 
to 3% of all the neoplasia affecting women, there were 
estimates of 48,020 cases of thyroid cancer in both gen-
ders in 2011. According to information from the National 
Cancer Institute in Brazil, the incidence of new thyroid 
cancers for 2012, gross rate/100 thousand women, varied 
between 3.4 and 17.06 among the different geographic 
regions2.
As to histological type, adenocarcinoma is the most 
frequent type, reaching 90% of all the cases in different 
series. Sarcomas, lymphomas and metastases to the thyroid 
gland are not very much described in the literature.
Sarcomas have a described prevalence of ap-
proximately 1%, and 15% to 20% of them happen in the 
head and neck; 0.014% of the sarcomas are primary of 
the thyroid. Its cytological diagnosis in preoperative tests 
is not easy, and its cytology may be mistaken with other 
thyroid neoplastic lesion, such as anaplastic and medullar 
carcinomas3.
Lymphomas have a thyroid prevalence between 
0.6% and 5%; there is a clinical past of Hashimoto thyroid-
itis in 27% to 100% of the cases. There may be Hodgkin 
and Non-Hodgkin lymphoma, and the B-cell Non-Hodgkin 
is the most prevalent4.
Metastases to the thyroid are not often described, 
having a low incidence. There are descriptions of me-
tastases from a primary kidney lesion, melanoma, lung, 
parathyroid, salivary gland and breast cancer5. However, 
in a study carried out in autopsies from patients which 
cause of death was malignant neoplasia, they reported 
that metastases to the thyroid gland is usually a terminal 
event, and it may happen in up to 120 months after the 
diagnosis of primary neoplasia and, when diagnosed, the 
patient already has a bad prognosis6,7.
This paper aims at doing a descriptive analysis of 
the rare histological types of thyroid cancer in a tertiary 
reference center.
METHODS
This paper was approved by the Ethics Committee 
in Research of the Institution where it was done.
We carried out a retrospective study of a series 
of cases, studying 3,018 charts from patients with thy-
roid disease submitted to a surgical procedure between 
1977 and 2010. We collected demographic information 
associated with the diagnosis, treatment and histopatho-
logical results.
RESULTS
We studied the surgical causes of thyroid disease, 
encompassing a total of 3,018 cases. Of these, we found 
histological benign disease in 72% of the cases, the most 
prevalent was colloid goiter; 21% of the cases were papil-
liferous tumors; 4.7% follicular neoplasia; undifferentiated 
carcinoma was found in 0.73%; and medullary corre-
sponded to 0.36%.
Histological types were the lymphomas (Figure 1), 
sarcomas (Figure 2), undifferentiated carcinomas, med-
ullary carcinoma and metastases to the thyroid gland, 
which together corresponded to less than 1.30% of the 
series - Table 1.
Figure 1. Microphotography of a thyroid lymphoma. HE, 400x.
Figure 2. Microphotography of a thyroid fusiform sarcoma. HE, 400x.
Assessing the series as to neoplastic histology, the 
result was a predominance of well-differentiated thyroid carci-
noma, corresponding to 95% of the cases; followed by undif-
ferentiated carcinomas, 2.7%, and medullary, 1.3% - Table 2.
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Table 1. Distribution of cases according to histological type.
Pathology Number of cases %
Benign lesions 2194 72.6
Papilliferous carcinoma 645 21.4
Follicular carcinoma 141 4.7
Undifferentiated carcinoma 22 0.73
Medullary carcinoma 11 0.36
Sarcoma 2 0.07
Lymphoma 2 0.07
Metastasis 1 0.07
Total 3018 100
Table 2. Distribution of the cases according malignant histo-
logical types.
Malignant neoplasia Number of cases %
Papilliferous carcinoma 645 78.3
Follicular carcinoma 141 17.1
Undifferentiated carcinoma 22 2.7
Medullary carcinoma 11 1.3
Sarcoma 2 0.24
Lymphoma 2 0.24
Metastasis 1 0.12
Total 824 100
Concerning the rare types of thyroid cancer, we had 
38 cases (4.61%), which most had bad clinical outcomes 
(Figure 3).
Figure 3. Microphotography of a thyroid carcinoid tumor. HE, 100x.
DISCUSSION
After assessing 3,018 charts of thyroid disease cases 
operated, we had 95.4% of the patients submitted to surgi-
cal treatment for thyroid neoplasia, with histology reports 
of well-differentiated thyroid carcinoma and only 0.6% of 
the patients were diagnosed with lymphoma, sarcoma or 
metastases to the thyroid gland, and such data match those 
published in the literature8.
The undifferentiated carcinoma, contrary to 
other types of thyroid carcinoma, have a very ag-
gressive behavior, regardless of treatment type, and 
knowing its clinical and pathological characteristics is 
very important to establish the best treatment9. In our 
series, it was the most frequent histological type, with a 
predominance in females (65% of the cases). In general, 
upon clinical presentation it is possible to make a preo-
perative clinical diagnosis, because they have symptoms 
associated to a fast growth neck tumor compressing the 
upper digestive and air ways. In this series, all the patients 
died.
Primary thyroid lymphomas have a large spec-
trum, among which we may distinguish Hodgkin lym-
phoma and non-Hodgkin lymphoma of large cells, 
low-grade MALT lymphomas, low-grade B-cell lympho-
mas with plasmacytic differentiation, Burkitt lympho-
ma and delta gama lymphoma, and the non-Hodgkin 
B lymphoma the most frequent lympho-proliferative 
neoplasia in this gland, as well as B-cell high-grade lym-
phomas which are more common than the low grade 
ones4.
Primary thyroid lymphomas happen more frequent 
in women than in men, involving individuals with ages 
between 50 and 80 years, with an incidence peak in the 
sixth decade of life; having an annual incidence of two 
cases per million inhabitants, representing about 2% of 
the extranodal lymphomas10. According to the literature, 
there is a greater incidence of lymphoma in the cases of 
autoimmune thyroiditis11.
The most common clinical presentation of this 
type of tumor is similar to that of the thyroid anaplastic 
carcinoma and is based on a sudden growth in the neck, 
often times associated to obstructive symptoms12. The 
outcome may be favorable if the diagnosis is early and 
the treatment is specific.
As to sarcomas, the diagnosis of a primary thyroid 
lesion requires much prudence, since leiomyosarcoma in 
the neck are more common than primary thyroid lesions 
and may invade the gland. By the same token, the pri-
mary thyroid lesion may also involve adjacent structures, 
spilling over the thyroid capsule, which causes diagnostic 
confusion3.
With the help of immunohistochemistry and elec-
tronic microscopy, it has been shown that most of the 
sarcomatous lesions of the thyroid gland are undifferen-
tiated carcinomas with sarcomatous differentiation, with 
epithelial origin and not mesenchymal, which may show 
expression of vimentin and cytokeratin , besides the oc-
casional expression of thyroglobulin, but do not show the 
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expression of desmin, muscle-specific actin, chromogranin 
or calcitonin13. Such analysis could not be carried out in a 
review in our service, since the slides dated of early 80‘s, 
with compromise of its characteristics.
Concerning metastasis to the thyroid gland, most 
of the patients are asymptomatic, corroborating its sub-
diagnosis. Its incidence varies between 1.4 to 4%7. None-
theless, in autopsy studies, the incidence can get to 24%. 
Although the presentation with thyroid metastatic lesion 
be considered indicative of a terminal disease, upon detec-
ting thyroid-limited disease, it must be treated surgically. 
In the case reported in our service, the patient died after 
the diagnosis.
CONCLUSION
There are very few described cases of sarcomas, 
lymphoma and metastases to the thyroid gland. Rare cases 
of malignant thyroid neoplasia correspond to 0.5% of our 
series, with a bad clinical outcome.
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